XINSHIPING is the second calcium channel blocker (CCB) that has adopted controlled release technology and passed the consistency evaluation in China. The drug is released at a uniform rate over 24 hours through the laser hole in the outer protective film of the tablet, avoiding the phenomenon where plasma concentration peaks and drops drastically, ensuring a stable and long-lasting hypotensive effect.